Interactions between von willebrand factor and factor viii: Where did they first meet

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 3, 2000, Pages 269-275

  Montgomery, Robert R ^a   Gill, Joan Cox ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; COMPLEMENTARY DNA; DESMOPRESSIN ACETATE; RECOMBINANT BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ANIMAL CELL; AUTOSOMAL INHERITANCE; CASE REPORT; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE MUTATION; GENE THERAPY; HEMOPHILIA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SYNDROME DELINEATION; VON WILLEBRAND DISEASE;

ANIMALS; CATTLE; CHROMOSOMES, HUMAN, PAIR 12; CYTOPLASMIC GRANULES; DEAMINO ARGININE VASOPRESSIN; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FACTOR VIII; FEMALE; GENE THERAPY; GENOTYPE; HEMOPHILIA A; HUMANS; MACROMOLECULAR SUBSTANCES; MALE; MICE; MODELS, BIOLOGICAL; PITUITARY NEOPLASMS; PLATELET ADHESIVENESS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR; X CHROMOSOME;

EID: 0034455182     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200005000-00017     Document Type: Article

References (27)

1. Rosner F. Hemophilia in the Talmud and Rabbinic writings. Ann Intern Med 1969;70:833.
2. Brinkhous KM. A short history of hemophilia, with some comments on the word "hemophilia". In: Brinkhous KM, Hemker HC, eds. Handbook of Hemophilia. New York: American Elsevier, 1975:3-20.
3. Wright AE. On a method of determining the condition of blood coagulability for clinical and experimental purposes, and on the effect of the administration of calcium salts in hemophilia and actual or threatened hemorrhage. Br Med J 1893;2:223.
4. von Willebrand E. Hereditär pseudohemofi. Finska Lak Handl 1926;68:87.
5. Zimmerman TS, Ratnoff OD, Powell AE. Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest 1971;50:244-54.
6. Howard MA, Firkin BG. Ristocetin: A new tool in the investigation of platelet. Thromb Diath Haemorrhagica 1971;26:362-369.
7. Weiss HJ, Hoyer IW. von Willebrand factor: Dissociation from antihemophilic factor procoagulant activity. Science 1973;182:1149-1151.
8. Vehar GA, Keyt V, Eaton D, et al. Structure of human factor VIII. Nature 1984;312:337-42.
9. Lollar P. Structure and function of Factor VIII. Adv Exp Med Biol 1995;386:3-17.
10. Pittman DD, Marquette KA, Kaufman RJ. Role of the B domain for factor VIII and factor V expression and function. Blood 1994;84:4214-25.
11. Fay PJ, Kawai Y, Wagner DD, Ginsburg D, Bonthron D, Ohlsson-Wilhelm BM, Chavin SI, Abraham GN, Handin RI, Orkin SH, Montgomery RR, Marder VJ. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 1986;232:995-8.
12. Montgomery RR, Zimmerman TS. von Willebrand's disease antigen II: A new plasma and platelet antigen deficient in severe von Willebrand's disease. J Clin Invest 1978;61:1498.
13. Furlan M, Robles R, Lamie B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-34.
14. Ruggeri ZM. Structure and function of von Willebrand factor: relationship to von Willebrand's disease. Mayo Clin Proc 1991;66:847-61.
15. Goudemand J, Mazurier C, Marey Am Caron C, Coupez B, Mizon P, Goudemand M. Clinical and biologic evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity. Br J Haematol 1992;80(2):214-21.
16. Hensen A, Mattern MJ, Loeliger EA. Haemophilia A with apparently autosomal dominant inheritance. Evidence for a second autosomal locus involved in factor 8 production. Thromb Diath Haemorrhagica 1965;14:341-5.
17. Weltkamp JJ, van Tilburg NH. "Autosomal hemophilia": a variant of von Willebrand's disease. Br J Haematol 1974;26:141-52.
18. Montgomery RR, Hathaway WE, Johnson J, Jacobson L. A variant of von Willebrand's disease with abnormal expression factor VIII procoagulant activity. Blood 1982;60:201-7.
19. Jorieux S, Mercier B, Oukfir D. Mazurier C. The "Normandy" variant of von Willebrand disease: characterization. Blood 1991;77:1937-41.
20. 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem 1991;266:19146-9.
21. Cacheris PM, Nichols WC, Ginsburg D. Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 1991;266:13499-502.
22. Gaucher C, Jorieux S, Mercier B, Oufir D, Mazurier C. The "Normandy" variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene. Blood 1991;77:1937-41.
23. Gaucher C, Mercier B, Jorieux S, Oufkir D, Mazurier C. Identification of two point mutations in the von Willebrand factor gene of three families with the "Normandy" variant of von Willebrand disease. Br J Haematol 1991;78:506-14.
24. Kroner PA, Foster PA, Fahs SA, Montgomery RR. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood 1996;87:1013-21.
25. Kaufman RJ, Wasley LC, Davies MV, Wise RJ, Israel DI, Dorner AJ. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol Cell Biol 1989;9:1233-42.
26. Mayadas TN, Wagner DD. von Willebrand factor biosynthesis and processing. Ann NY Acad Sci 1991;614:153-66.
27. Kaufman RJ. Biological regulation of factor VII activity. Annu Rev Med 1992;43:325-39.